A MESSAGE FROM TERRY GREGG
As you may know, Type 1 Diabetes (T1D) is an autoimmune condition that requires constant daily attention, can be life threatening and currently has no cure. Blood glucose levels must be monitored constantly and insulin must be injected 4-6 times each and every day to stay alive.
Dexcom’s innovative continuous glucose monitor (CGM) is designed to help people with diabetes more conveniently and effectively manage their blood sugar levels. Our product helps ease the management of this disease – but it is not a cure. Which is why I am asking you to join me in support of JDRF.
JDRF-funded research has led to treatments and therapies that have significantly improved the lives of people with T1D. JDRF is the only organization focused on T1D research and the only organization with a strategic plan to bring those living with T1D a continuous flow of life-changing therapies and, ultimately, a cure for the disease and its complications.
As this year's Promise Ball Corporate Honoree, we would love to have your support. Please consider making a donation to JDRF to support our fundraising efforts.
